-
Send to Friends (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Checklist of Responsibilities for the Scientific Editor of This Article
Publishing Process of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3855)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 14, 2021 (publication date) through Feb 5, 2023
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sun LQ, Peng LS, Guo JF, Jiang F, Cui F, Huang HJ, Jin ZD. Validation of serum tumor biomarkers in predicting advanced cystic mucinous neoplasm of the pancreas. World J Gastroenterol 2021; 27(6): 501-512 [PMID: 33642824 DOI: 10.3748/wjg.v27.i6.501] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v27/i6/501.htm |
| Number | Citing Articles |
| 1 |
Daniel Keefe, Rasheid Smith, Bingtao Gao, Walla I. Malkawi, Sean M. Geary, Pashtoon M. Kasi, Saima Sharif, Aliasger K. Salem, Fatima Toor. Colorectal Cancer Biosensor Using Vertically-Oriented Silicon Nanowires. 2022 IEEE Sensors 2022; : 1 doi: 10.1109/SENSORS52175.2022.9967069
|
| 2 |
Tongwei Zhao, Guangyun Mao, Ming Chen, Tao Huang. The Role of Change Rates of CYFRA21-1 and CEA in Predicting Chemotherapy Efficacy for Non-Small-Cell Lung Cancer. Computational and Mathematical Methods in Medicine 2021; 2021: 1 doi: 10.1155/2021/1951364
|
| 3 |
Miłosz Caban, Ewa Małecka-Wojciesko. Pancreatic Incidentaloma. Journal of Clinical Medicine 2022; 11(16): 4648 doi: 10.3390/jcm11164648
|
| 4 |
Jiang Liu, Ying Xing, Liqi Sun. Commentary: The Tumor Markers and Blood Inflammation Markers Are More Likely to Be the Indicators for Differentiating Benign and Malignant Pancreatic Mucinous Cystic Neoplasms. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.901010
|